Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Dainippon reports anti-H. pylori compounds

April 26, 1996

EPC-K for pancreatitis

April 26, 1996

Byk Gulden claims agents for H. pylori control

April 26, 1996

Enadoline claimed for treatment of BPH

April 26, 1996

5alpha-Reductase inhibitors for BPH disclosed by Lilly

April 26, 1996

SR-48692 claimed for use as diuretic

April 26, 1996

NOS inhibitors claimed by Ono

April 26, 1996

Antirestenosis agents reported by Fujisawa, Teijin

April 26, 1996

ACE/NEP inhibitors claimed by Fujisawa

April 26, 1996

New Glaxo Wellcome compounds protect against leukocyte-induced tissue damage

April 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.